Twenty years on: the impact of fragments on drug discovery

Erlanson, Daniel A., Fesik, Stephen W., Hubbard, Roderick E., Jahnke, Wolfgang, Jhoti, Harren·2016·Nature Reviews Drug Discovery

DOI 10.1038/nrd.2016.109

Cited by (1,000)

Items 201–300 of 1,000

Development and biological applications of sulfur–triazole exchange (SuTEx) chemistry
Adam L. Borne, Jeffrey W. Brulet, Kun Yuan, Ku‐Lung Hsu · 2021 · RSC Chemical Biology
Fragment-Guided Discovery of Pyrazole Carboxylic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2 Related Factor 2 (KEAP1:NRF2) Protein−Protein Interaction
David Norton, William G. Bonnette, James F. Callahan, Maria G. Carr, Charlotte Griffiths-Jones, Tom D. Heightman, Jeffrey K. Kerns, Hong Nie, Sharna J. Rich, Caroline J. Richardson et al. · 2021 · Journal of Medicinal Chemistry
Targeting tuberculosis using structure-guided fragment-based drug design
V. Mendes, Tom L. Blundell · 2016 · Drug Discovery Today
Metal-Binding Isosteres as New Scaffolds for Metalloenzyme Inhibitors
Benjamin L. Dick, Seth M. Cohen · 2018 · Inorganic Chemistry
Approaches for the discovery of metallo‐β‐lactamase inhibitors: A review
Cheng Shi, Jiaxing Chen, Xinyue Kang, Xutong Shen, Xingzhen Lao, Heng Zheng · 2019 · Chemical Biology & Drug Design
Fsp 3 -rich and diverse fragments inspired by natural products as a collection to enhance fragment-based drug discovery
Abigail R. Hanby, Nikolaj S. Troelsen, Thomas J. Osberger, Sarah L. Kidd, Kim T. Mortensen, David R. Spring · 2020 · Chemical Communications
Augmenting Hit Identification by Virtual Screening Techniques in Small Molecule Drug Discovery
Xin Cindy Yan, John M. Sanders, Ying-Duo Gao, Matthew Tudor, Andrew M. Haidle, Daniel J. Klein, Antonella Converso, Charles A. Lesburg, Yi Zang, Harold B. Wood · 2020 · Journal of Chemical Information and Modeling
Allosteric Targeting of the Fanconi Anemia Ubiquitin-Conjugating Enzyme Ube2T by Fragment Screening
Francesca Ester Morreale, Alessio Bortoluzzi, Viduth K. Chaugule, Connor Arkinson, Helen Walden, Alessio Ciulli · 2017 · Journal of Medicinal Chemistry
Protein–Small Molecule Interactions by WaterLOGSY
Renjie Huang, Ivanhoe K. H. Leung · 2018 · Methods in enzymology on CD-ROM/Methods in enzymology
Interaction Energetics and Druggability of the Protein–Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2)
Mengqi Zhong, A.J. Lynch, Samantha N. Muellers, Stefan Jehle, Lingqi Luo, David R. Hall, Reina Iwase, James P. Carolan, Megan E. Egbert, Amanda Wakefield et al. · 2019 · Biochemistry
Applied Biophysical Methods in Fragment-Based Drug Discovery
Joe Coyle, Reto Walser · 2020 · SLAS DISCOVERY
Pyrimidone inhibitors targeting Chikungunya Virus nsP3 macrodomain by fragment-based drug design
Sixue Zhang, Atefeh Garzan, Nicole N. Haese, Robert J. Bostwick, Yohanka Martinez-Gzegozewska, Lynn A. Rasmussen, Daniel N. Streblow, Mark T. Haise, Ashish K. Pathak, Corinne E. Augelli‐Szafran et al. · 2021 · PLoS ONE
A structural perspective on targeting the RTK /Ras/ MAP kinase pathway in cancer
David E. Heppner, Michael J. Eck · 2021 · Protein Science
From Static to Dynamic Structures: Improving Binding Affinity Prediction with Graph‐Based Deep Learning
Yaosen Min, Wei Ye, Peizhuo Wang, Xiaoting Wang, Han Li, Nian Wu, Stefan Bauer, Shuxin Zheng, Yu Shi, Yingheng Wang et al. · 2024 · Advanced Science
Targeting protein disorder: the next hurdle in drug discovery
Tamás Lázár, Acadia Connor, Charles F. DeLisle, Virginia Burger, Péter Tompa · 2025 · Nature Reviews Drug Discovery
Construction of a 3D-shaped, natural product like fragment library by fragmentation and diversification of natural products
Horst Prescher, Guido Koch, Tim Schuhmann, Peter Ertl, Alex Bussenault, Meir Glick, Ina Dix, Frank Petersen, Dimitrios E. Lizos · 2016 · Bioorganic & Medicinal Chemistry
Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2
Qiufeng Liu, Fubao Huang, Xiaojing Yuan, Kai Wang, Yi Zou, Jianhua Shen, Yechun Xu · 2017 · Journal of Medicinal Chemistry
Biophysical methods in early drug discovery
Geoffrey A. Holdgate, Kevin J. Embrey, Alexander G. Milbradt, Gareth M. Davies · 2019 · ADMET & DMPK
Discovery of allosteric binding sites by crystallographic fragment screening
Tobias J. Krojer, James S. Fraser, F. von Delft · 2020 · Current Opinion in Structural Biology
The most common linkers in bioactive molecules and their bioisosteric replacement network
Peter Ertl, Eva Altmann, Sophie Racine · 2023 · Bioorganic & Medicinal Chemistry
Fragment Screening and Fast Micromolar Detection on a Benchtop NMR Spectrometer Boosted by Photoinduced Hyperpolarization
Gabriela R. Stadler, Takuya F. Segawa, Matthias Bütikofer, Venita Decker, Sandra Loss, Barbara Czarniecki, Felix Torres, Roland Riek · 2023 · Angewandte Chemie International Edition
Target-based drug discovery: Applications of fluorescence techniques in high throughput and fragment-based screening
Vikrant Kumar, Puneeth Kumar Chunchagatta Lakshman, T.K. Prasad, Kavyashree Manjunath, Sneha G. Bairy, Akshaya S. Vasu, B. Ganavi, Subbarao Jasti, Neelagandan Kamariah · 2023 · Heliyon
Fragment-Based Discovery and Optimization of Enzyme Inhibitors by Docking of Commercial Chemical Space
Axel Rudling, Robert Gustafsson, Ingrid Almlöf, Evert J. Homan, Martin Scobie, Ulrika Warpman Berglund, Thomas Helleday, Pål Stenmark, Jens Carlsson · 2017 · Journal of Medicinal Chemistry
C–H functionalisation tolerant to polar groups could transform fragment-based drug discovery (FBDD)
Gianni Chessari, Rachel Grainger, Rhian S. Holvey, R. Frederick Ludlow, Paul N. Mortenson, David C. Rees · 2021 · Chemical Science
Substrate mediated enzyme prodrug therapy
Betina Fejerskov, Morten T. Jarlstad Olesen, Alexander N. Zelikin · 2017 · Advanced Drug Delivery Reviews
Fragment Binding to the Nsp3 Macrodomain of SARS-CoV-2 Identified Through Crystallographic Screening and Computational Docking
Marion Schuller, G.J. Correy, Stefan Gahbauer, D. Fearon, Taiasean Wu, Roberto Efraín Díaz, I.D. Young, Luan Carvalho Martins, Dominique H. Smith, Ursula Schulze‐Gahmen et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Multicomponent coupling and macrocyclization enabled by Rh(III)-catalyzed dual C–H activation: Macrocyclic oxime inhibitor of influenza H1N1
Hao Wang, Zhongyu Li, Xiangyang Chen, Jonathan J. Wong, Tongyu Bi, Xiankun Tong, Zhongliang Xu, Mingyue Zhen, Yunhui Wan, Tang Li et al. · 2022 · Chem
Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors
Florian Wittlinger, Blessing C. Ogboo, Ekaterina Shevchenko, Tahereh Damghani, Calvin D. Pham, Ilse K. Schaeffner, Brandon T. Oligny, Surbhi P. Chitnis, Tyler S. Beyett, Alexander Rasch et al. · 2024 · Communications Chemistry
Recent advances in small molecule inhibitors of deubiquitinating enzymes
Pengwei Liu, Zhengyang Chen, Yiting Guo, Qiaojun He, Chenghao Pan · 2025 · European Journal of Medicinal Chemistry
How Size Matters: Diversity for Fragment Library Design
Yun Yu Shi, Mark von Itzstein · 2019 · Molecules
Library Design Strategies To Accelerate Fragment‐Based Drug Discovery
Nikolaj S. Troelsen, Mads H. Clausen · 2020 · Chemistry - A European Journal
CAVIAR: a method for automatic cavity detection, description and decomposition into subcavities
Jean‐Rémy Marchand, Bernard Pirard, Peter Ertl, Finton Sirockin · 2021 · Journal of Computer-Aided Molecular Design
An Exploration of Chemical Properties Required for Cooperative Stabilization of the 14-3-3 Interaction with NF-κB—Utilizing a Reversible Covalent Tethering Approach
M. Wolter, Dario Valenti, Peter J. Cossar, Stanimira Hristeva, Laura M. Levy, Thorsten Genski, Torsten Hoffmann, Luc Brunsveld, Dimitrios Tzalis, Christian Ottmann · 2021 · Journal of Medicinal Chemistry
Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies
Abdulrahim Altoam Alzain, Fatima A. Elbadwi, Fatima O. Alsamani · 2022 · Informatics in Medicine Unlocked
The Science and Art of Structure-Based Virtual Screening
Hongtao Zhao · 2024 · ACS Medicinal Chemistry Letters
Chemical tools to expand the ligandable proteome: Diversity-oriented synthesis-based photoreactive stereoprobes
Ogasawara, Daisuke, Konrad, David B., Tan, Zher Yin, Carey, Kimberly L., Luo, Jessica, Won, Sang Joon, Li, Haoxin, Carter, Trever R., DeMeester, Kristen E., Njomen, Evert et al. · 2024 · Cell Chemical Biology
Allosteric Activation of Striatal-Enriched Protein Tyrosine Phosphatase (STEP, PTPN5) by a Fragment-like Molecule
Christofer S. Tautermann, Florian P. C. Binder, Frank H. Büttner, Christian Eickmeier, Dennis Fiegen, Ulrike Gross, Marc A. Grundl, Ralf Heilker, Scott Hobson, S. Hoerer et al. · 2018 · Journal of Medicinal Chemistry
Fast NMR Methods for Measuring in the Direct and/or Competition Mode the Dissociation Constants of Chemical Fragments Interacting with a Receptor
Claudio Dalvit, Annick Parent, François Vallée, Magali Mathieu, Alexey Rak · 2019 · ChemMedChem
Rapid Elaboration of Fragments into Leads by X-ray Crystallographic Screening of Parallel Chemical Libraries (REFiLX)
M.R. Bentley, Olga V. Ilyichova, Geqing Wang, Martin L Williams, Gaurav Sharma, Wesam S. Alwan, Rebecca L. Whitehouse, Biswaranjan Mohanty, Peter J. Scammells, Begoña Heras et al. · 2020 · Journal of Medicinal Chemistry
Chemical biology and medicinal chemistry of RNA methyltransferases
Tim R. Fischer, J. Laurenz Meidner, Marvin Schwickert, Marlies Weber, Robert A. Zimmermann, Christian Kersten, Tanja Schirmeister, Mark Helm · 2022 · Nucleic Acids Research
Multi-target QSAR modelling of chemo-genomic data analysis based on Extreme Learning Machine
Ahmed M. Anter, Yasmine S. Moemen, Ashraf Darwish, Aboul Ella Hassanien · 2019 · Knowledge-Based Systems
Structure-based view of the druggable genome
Jiayan Wang, Setayesh Yazdani, Ana Han, Matthieu Schapira · 2020 · Drug Discovery Today
Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures
Lisa M. Baker, A. Aimon, James B. Murray, Allan E. Surgenor, Natalia Matassova, Stephen D. Roughley, P.M. Collins, Tobias J. Krojer, F. von Delft, Roderick E. Hubbard · 2020 · Communications Chemistry
Pharmacophore-Oriented Discovery of Novel 1,2,3-Benzotriazine-4-one Derivatives as Potent 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors
Yao-Chao Yan, Wei Wu, Guang-Yi Huang, Wen‐Chao Yang, Qiong Chen, Ren‐Yu Qu, Hong‐Yan Lin, Guang‐Fu Yang · 2022 · Journal of Agricultural and Food Chemistry
Inhibition of Akt and other AGC kinases: A target for clinical cancer therapy?
Vincent Prêtre, Andreas N. WICKI · 2017 · Seminars in Cancer Biology
cryoEM‐Guided Development of Antibiotics for Drug‐Resistant Bacteria
Matthew J. Belousoff, Hariprasad Venugopal, Alexander I. Wright, Samuel Seoner, Isabella Stuart, Christopher J. Stubenrauch, Rebecca S. Bamert, David W. Lupton, Trevor J. Lithgow · 2019 · ChemMedChem
Discovery of Novel KRAS-PDEδ Inhibitors by Fragment-Based Drug Design
Chen, Long, Zhuang, Chunlin, Lu, Junjie, Jiang, Yan, Sheng, Chunquan · 2018 · Journal of Medicinal Chemistry
Proteome‐Wide Fragment‐Based Ligand and Target Discovery
Ines Forrest, Christopher G. Parker · 2023 · Israel Journal of Chemistry
Accelerating Drug Discovery With High‐Throughput Crystallographic Fragment Screening and Structural Enablement
D. Fearon, A.J. Powell, A. Douangamath, Alexandre M.M. Dias, Charles W.E. Tomlinson, Blake H. Balcomb, Jasmin Cara Aschenbrenner, A. Aimon, Isabel A. Barker, Felicity Bertram et al. · 2024 · Applied Research
Harnessing the Versatility of Optical Biosensors for Target-Based Small-Molecule Drug Discovery
Tim Patrick Kaminski, Anders Gunnarsson, Stefan Geschwindner · 2016 · ACS Sensors
Protein‐Templated Formation of an Inhibitor of the Blood Coagulation Factor Xa through a Background‐Free Amidation Reaction
Mike Jaegle, Torsten Steinmetzer, Jörg Rademann · 2017 · Angewandte Chemie International Edition
Sustainable Practices in Medicinal Chemistry Part 2: Green by Design
Ignacio Aliagas, Raphaëlle Berger, Kristin Goldberg, Rachel T. Nishimura, John Reilly, Paul Richardson, Daniel Richter, Edward C. Sherer, Brian A. Sparling, Marian C. Bryan · 2017 · Journal of Medicinal Chemistry
Advances in Lead Generation
Joerg Holenz, Patrick Stoy · 2018 · Bioorganic & Medicinal Chemistry Letters
Machine Learning Algorithm Identifies an Antibiotic Vocabulary for Permeating Gram-Negative Bacteria
Rachael A. Mansbach, Inga V. Leus, Jitender Mehla, César A. López, John K. Walker, Valentin V. Rybenkov, Nicolas Hengartner, Helen I. Zgurskaya, Sandrasegaram Gnanakaran · 2020 · Journal of Chemical Information and Modeling
Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity
Yousuke Yamada, Hajime Takashima, Lee Walmsley, Fumihito Ushiyama, Yohei Matsuda, Harumi Kanazawa, Toru Yamaguchi-Sasaki, Nozomi Tanaka-Yamamoto, Junya Yamagishi, Risa Kurimoto-Tsuruta et al. · 2020 · Journal of Medicinal Chemistry
Pharmaceutical applications of framework nucleic acids
Liang Chen, Jie Zhang, Zhun Lin, Ziyan Zhang, Miao Mao, Jiacheng Wu, Qian Li, Yuanqing Zhang, Chunhai Fan · 2021 · Acta Pharmaceutica Sinica B
Tetramethylammonium Fluoride: Fundamental Properties and Applications in C-F Bond-Forming Reactions and as a Base
Vladimir Iashin, Tom Wirtanen, Jesús E. Perea‐Buceta · 2022 · Catalysts
Peptide-to-Small Molecule: A Pharmacophore-Guided Small Molecule Lead Generation Strategy from High-Affinity Macrocyclic Peptides
Shuhei Yoshida, Shota Uehara, Noriyasu Kondo, Yu Takahashi, Shiho Yamamoto, Atsushi Kameda, Soichiro Kawagoe, Naoko Inoue, Masami Yamada, Norito Yoshimura et al. · 2022 · Journal of Medicinal Chemistry
Mapping oncogenic protein interactions for precision medicine
Mehdi Sharifi Tabar, Habib Francis, Dannel Yeo, Charles G. Bailey, John E.J. Rasko · 2022 · International Journal of Cancer
Identification of a New Zinc Binding Chemotype by Fragment Screening
Panagiotis K. Chrysanthopoulos, Prashant Mujumdar, Lucy A. Woods, Olan Dolezal, Bin Ren, Thomas S. Peat, Sally‐Ann Poulsen · 2017 · Journal of Medicinal Chemistry
Inhibition of autotransporter biogenesis by small molecules
Maurice Steenhuis, Abdallah M. Abdallah, Sabrina M. de Munnik, Sebastiaan Kuhne, Geert-Jan Sterk, H. Bart van den Berg van Saparoea, Sibel Westerhausen, Samuel Wagner, Nicole N. van der Wel, Maikel Wijtmans et al. · 2019 · Molecular Microbiology
The role of E3 ubiquitin ligase HECTD3 in cancer and beyond
Qiuyun Jiang, Fubing Li, Zhuo Cheng, Yanjie Kong, Ceshi Chen · 2019 · Cellular and Molecular Life Sciences
Targeting a critical step in fungal hexosamine biosynthesis
Deborah E. A. Lockhart, Mathew Stanley, Olawale G. Raimi, David A. Robinson, Dominika Boldovjáková, Daniel R. Squair, Andrew T. Ferenbach, Wenxia Fang, Daan M. F. van Aalten · 2020 · Journal of Biological Chemistry
On-DNA hit validation methodologies for ligands identified from DNA-encoded chemical libraries
Luca Prati, Martina Bigatti, Etienne J. Donckèle, Dario Neri, Florent Samain · 2020 · Biochemical and Biophysical Research Communications
Auto In Silico Ligand Directing Evolution to Facilitate the Rapid and Efficient Discovery of Drug Lead
Fengxu Wu, Linsheng Zhuo, Fan Wang, Wei Huang, Ge‐Fei Hao, Guang‐Fu Yang · 2020 · iScience
The current toolbox for APOBEC drug discovery
Michael J. Grillo, Katherine F. M. Jones, Michael A. Carpenter, Reuben S. Harris, Daniel A. Harki · 2022 · Trends in Pharmacological Sciences
Rational Design of a Novel Tubulin Inhibitor with a Unique Mechanism of Action
Tobias Mühlethaler, Lampros Milanos, Jose Antonio Ortega, Thorsten B. Blum, Dario Gioia, Bibhas Roy, Andrea Enrico Prota, Andrea Cavalli, Michel Olivier Steinmetz · 2022 · Angewandte Chemie International Edition
X-ray Screening of an Electrophilic Fragment Library and Application toward the Development of a Novel ERK 1/2 Covalent Inhibitor
Jeffrey D. St. Denis, Gianni Chessari, Anne Cleasby, Benjamin D. Cons, Suzanna Cowan, Samuel E. Dalton, Charlotte East, Christopher W. Murray, Marc O’Reilly, Torren M. Peakman et al. · 2022 · Journal of Medicinal Chemistry
What makes a good fragment in fragment-based drug discovery?
Zenon D. Konteatis · 2021 · Expert Opinion on Drug Discovery
Natural product-informed exploration of chemical space to enable bioactive molecular discovery
Adam S. Nelson, George Karageorgis · 2020 · RSC Medicinal Chemistry
In silico fragment-based drug design with SEED
Jean‐Rémy Marchand, Amedeo Caflisch · 2018 · European Journal of Medicinal Chemistry
Impact of the Protein Data Bank on antineoplastic approvals
John Westbrook, Rose Soskind, Brian P. Hudson, Stephen Kevin Burley · 2020 · Drug Discovery Today
Targeting epigenetic reader domains by chemical biology
Alessandra Cipriano, Gianluca Sbardella, Alessio Ciulli · 2020 · Current Opinion in Chemical Biology
Is it time for biocatalysis in fragment-based drug discovery?
Jeremy I. Ramsden, Sebastian C. Cosgrove, Nicholas John Turner · 2020 · Chemical Science
Using biochemistry and biophysics to extinguish androgen receptor signaling in prostate cancer
Irfan Ahmed Asangani, Ian A. Blair, Gregory D. Van Duyne, Vincent J. Hilser, Vera Y. Moiseenkova‐Bell, Stephen R. Plymate, Cynthia C.T. Sprenger, A. Joshua Wand, T.M. Penning · 2020 · Journal of Biological Chemistry
Exploring structure-property relationships in magnesium dissolution modulators
Tim Würger, Di Mei, Bahram Vaghefinazari, David Alan Winkler, Sviatlana V. Lamaka, Mikhail L. Zheludkevich, Robert H. Meißner, Christian Feiler · 2021 · npj Materials Degradation
Integration of Lead Discovery Tactics and the Evolution of the Lead Discovery Toolbox
Melanie V. Leveridge, Chun‐wa Chung, Jeffrey W. Gross, Christopher B. Phelps, Darren V. S. Green · 2018 · SLAS DISCOVERY
Fragment-oriented synthesis: β-elaboration of cyclic amine fragments using enecarbamates as platform intermediates
Alexandre F. Trindade, Emily L. Faulkner, Andrew G. Leach, Adam S. Nelson, Stephen P. Marsden · 2020 · Chemical Communications
The Perturbed Free‐Energy Landscape: Linking Ligand Binding to Biomolecular Folding
Abdallah S. Abdelsattar, Youssef Mansour, Fareed Aboul‐ela · 2020 · ChemBioChem
Robust proteome profiling of cysteine-reactive fragments using label-free chemoproteomics
George S. Biggs, Emma E. Cawood, Aini Vuorinen, William J. McCarthy, Harry Wilders, Ioannis G. Riziotis, Antonie J. van der Zouwen, Jonathan Pettinger, Luke Nightingale, Peiling Chen et al. · 2025 · Nature Communications
Combining structure and genomics to understand antimicrobial resistance
Tanushree Tunstall, Stephanie Portelli, Jody Emile Phelan, Taane Gregory Clark, David Benjamin Ascher, Nicholas Furnham · 2020 · Computational and Structural Biotechnology Journal
Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence
José Teófilo Moreira‐Filho, Arthur C. Silva, Rafael Ferreira Dantas, Bárbara Figueira Gomes, Lauro Ribeiro Souza Neto, J. Brandão-Neto, Raymond J. Owens, Nicholas Furnham, Bruno J. Neves, Floriano Paes Silva et al. · 2021 · Frontiers in Immunology
Mycobacterium tuberculosis Malate Synthase Structures with Fragments Reveal a Portal for Substrate/Product Exchange
Hsiao‐Ling Huang, Inna V. Krieger, Maloy Kumar Parai, Vijay Gawandi, James C. Sacchettini · 2016 · Journal of Biological Chemistry
Discovery and structure-guided fragment-linking of 4-(2,3-dichlorobenzoyl)-1-methyl-pyrrole-2-carboxamide as a pyruvate kinase M2 activator
Yumi Matsui, Isao Yasumatsu, Takashi Asahi, Takahiro Kitamura, Kazuo Kanai, Osamu Ubukata, Hitoshi Hayasaka, Sachiko Takaishi, Hiroyuki Hanzawa, SHINICHI KATAKURA · 2017 · Bioorganic & Medicinal Chemistry
A Review on Deep Learning-driven Drug Discovery: Strategies, Tools and Applications
Sundaravadivelu Sumathi, Kanagaraj Suganya, Kandasamy Swathi, Balraj Sudha, Arumugam Poornima, Chalos Angel Varghese, Raghu Aswathy · 2023 · Current Pharmaceutical Design
Signaling through non-membrane nuclear phosphoinositide binding proteins in human health and disease
Jamal M. Bryant, Raymond D. Blind · 2018 · Journal of Lipid Research
Free Energies and Entropies of Binding Sites Identified by MixMD Cosolvent Simulations
Phani Ghanakota, Debarati DasGupta, Heather A. Carlson · 2019 · Journal of Chemical Information and Modeling
Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase Inhibitors
Curt D. Haffner, Adam K. Charnley, Christopher J. Aquino, Linda Casillas, M.A. Convery, Julie A. Cox, Mark A. Elban, Nicole C. Goodwin, Peter J. Gough, Pamela A. Haile et al. · 2019 · ACS Medicinal Chemistry Letters
Progress toward B-Cell Lymphoma 6 BTB Domain Inhibitors for the Treatment of Diffuse Large B-Cell Lymphoma and Beyond
Yong Ai, Lucia Hwang, Alexander D. MacKerell, Ari M. Melnick, Fengtian Xue · 2021 · Journal of Medicinal Chemistry
A fragment-based approach to assess the ligandability of ArgB, ArgC, ArgD and ArgF in the L-arginine biosynthetic pathway of Mycobacterium tuberculosis
Pooja Gupta, S.E. Thomas, Shaymaa A. Zaidan, Maria A. Pasillas, James Cory-Wright, Víctor Sebastián-Pérez, Ailidh Burgess, Emma Cattermole, C. Meghir, Chris Abell et al. · 2021 · Computational and Structural Biotechnology Journal
Fast fragment- and compound-screening pipeline at the Swiss Light Source
Jakub W. Kaminski, Laura Vera, Dennis P. Stegmann, Jonatan Vering, Deniz Eris, Kate M. L. Smith, Chia‐Ying Huang, Nathalie Meier, Julia Steuber, Meitian Wang et al. · 2022 · Acta Crystallographica Section D Structural Biology
B-cell Lymphoma 6 Inhibitors: Current Advances and Prospects of Drug Development for Diffuse Large B-cell Lymphomas
Haijun Gu, Jia He, Yuzhan Li, Dazhao Mi, Tian Guan, Weikai Guo, Bo Liu, Yihua Chen · 2022 · Journal of Medicinal Chemistry
Fragment screening for drug leads by weak affinity chromatography (WAC-MS)
Sten Ohlson, Minh‐Dao Duong‐Thi · 2018 · Methods
Targeting RNA ‐binding proteins with small molecules: Perspectives, pitfalls and bifunctional molecules
Qingxin Li, CongBao Kang · 2023 · FEBS Letters
Discovery of Inhibitors of Four Bromodomains by Fragment-Anchored Ligand Docking
Jean‐Rémy Marchand, Andrea Dalle Vedove, Graziano Lolli, Amedeo Caflisch · 2017 · Journal of Chemical Information and Modeling
Overcoming Drug Resistance through the Development of Selective Inhibitors of UDP-Glucuronosyltransferase Enzymes
Michael J. Osborne, Luciana Coutinho de Oliveira, Laurent Volpon, Hiba Ahmad Zahreddine, Katherine L. B. Borden · 2018 · Journal of Molecular Biology
RNA–Ligand Interactions Quantified by Surface Plasmon Resonance with Reference Subtraction
J. Winston Arney, Kevin M. Weeks · 2022 · Biochemistry
PAC-FragmentDEL – photoactivated covalent capture of DNA-encoded fragments for hit discovery
Huiyong Ma, James B. Murray, Huadong Luo, Xue‐Min Cheng, Qiuxia Chen, Chao Song, Cong Duan, Ping Tan, Lifang Zhang, Jian Liu et al. · 2022 · RSC Medicinal Chemistry
Design, combinatorial synthesis and cytotoxic activity of 2-substituted furo[2,3-d]pyrimidinone and pyrrolo[2,3-d]pyrimidinone library
Buer Song, Lifei Nie, Khurshed A. Bozorov, Rustamkhon Kuryazov, Jiangyu Zhao, Haji Akber Aisa · 2022 · Molecular Diversity
Small Molecules Targeting the RNA-Binding Protein HuR Inhibit Tumor Growth in Xenografts
Xiaoqing Wu, Remya Ramesh, Jinan Wang, Youguang Zheng, Ahlam M. Armaly, Lanjing Wei, Minli Xing, Sudeshna Roy, Lan Lan, Fei Philip Gao et al. · 2023 · Journal of Medicinal Chemistry